Pharmaceutical Business review

Biogen Idec names new COO

Mr Hasler joined Biogen in 2001 from Wyeth Pharmaceuticals where he worked for eight years, serving since 1998 as senior vice president, head of global strategic marketing. Mr Hasler was also a member of the Wyeth executive committee and chairman of the commercial council.

From 1993 to 1998, Mr Hasler served in senior management capacities, including managing director of Wyeth Group, Germany; general manager of Wyeth in Switzerland; and general manager of Central Eastern Europe. Prior to joining Wyeth, Mr Hasler held several positions at Abbott and Sanofi Pharma in Switzerland.

James Mullen, CEO of Biogen, said: “Over the last few years, Hans Peter has led the great success and growth of our business outside the US. I am confident that we will continue meeting and exceeding our goals under his strong and capable leadership.”